Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C. (Record no. 14283425)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02515 a2200781 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250514155818.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200401s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 0887-6924 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1038/sj.leu.2403157 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Müller, M C |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20040123 |
| 245 00 - TITLE STATEMENT | |
| Title | Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Leukemia |
| Date of publication, distribution, etc. | Dec 2003 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 2392-400 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antimetabolites, Antineoplastic |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Agents |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Benzamides |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cross-Over Studies |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cytarabine |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cytogenetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Fusion Proteins, bcr-abl |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Imatinib Mesylate |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Interferon-alpha |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
| General subdivision | diagnosis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Piperazines |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prognosis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prospective Studies |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pyrimidines |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | RNA, Messenger |
| General subdivision | metabolism |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Recurrence |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Risk Factors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gattermann, N |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lahaye, T |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Deininger, M W N |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Berndt, A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fruehauf, S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Neubauer, A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fischer, T |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hossfeld, D K |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Schneller, F |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Krause, S W |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Nerl, C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sayer, H G |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ottmann, O G |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Waller, C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Aulitzky, W |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | le Coutre, P |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Freund, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Merx, K |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Paschka, P |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | König, H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kreil, S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Berger, U |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gschaidmeier, H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hehlmann, R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hochhaus, A |
| 773 0# - HOST ITEM ENTRY | |
| Title | Leukemia |
| Related parts | vol. 17 |
| -- | no. 12 |
| -- | p. 2392-400 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1038/sj.leu.2403157">https://doi.org/10.1038/sj.leu.2403157</a> |
| Public note | Available from publisher's website |
No items available.